Clinical trial
Clinical, Metabolic, and Immunoinflammatory Characteristics of Adult-Onset Diabetes at Diagnosis: A Cross-Sectional Study in the Kazakh Population
NCT07522502 is registered in ClinicalTrials.gov with West Kazakhstan Marat Ospanov Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical, Metabolic, and Immunoinflammatory Characteristics of Adult-Onset Diabetes at Diagnosis: A Cross-Sectional Study in the Kazakh Population
- Lead sponsor
- West Kazakhstan Marat Ospanov Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2024
- Completion date
- September 1, 2025
- Enrollment
- 240 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune diabetes, diabetes mellitus, type 2